Skip to main navigation Skip to search Skip to main content

SARS-CoV-2 multi-variant rapid detector based on graphene transistor functionalized with an engineered dimeric ACE2 receptor

  • Alice Romagnoli
  • , Mattia D'Agostino
  • , Eleonora Pavoni
  • , Chiara Ardiccioni
  • , Stefano Motta
  • , Paolo Crippa
  • , Giorgio Biagetti
  • , Valentina Notarstefano
  • , Jesmina Rexha
  • , Nunzio Perta
  • , Simone Barocci
  • , Brianna K. Costabile
  • , Gabriele Colasurdo
  • , Sara Caucci
  • , Davide Mencarelli
  • , Claudio Turchetti
  • , Marco Farina
  • , Luca Pierantoni
  • , Anna La Teana
  • , Richard Al Hadi
  • Francesco Cicconardi, Mauro Chinappi, Emiliano Trucchi, Filippo Mancia, Stefano Menzo, Blasco Morozzo della Rocca, Ilda D'Annessa, Daniele Di Marino
  • Marche Polytechnic University
  • National Biodiversity Future Center
  • University of Milan - Bicocca
  • ASUR Marche AV1
  • Columbia University
  • University of Bologna
  • Alcatera Inc
  • University of Bristol
  • University of Rome Tor Vergata
  • National Research Council of Italy

Research output: Contribution to journal › Journal Article › peer-review

35 Citations (Scopus)

Abstract

Reliable point-of-care (POC) rapid tests are crucial to detect infection and contain the spread of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). The emergence of several variants of concern (VOC) can reduce binding affinity to diagnostic antibodies, limiting the efficacy of the currently adopted tests, while showing unaltered or increased affinity for the host receptor, angiotensin converting enzyme 2 (ACE2). We present a graphene field-effect transistor (gFET) biosensor design, which exploits the Spike-ACE2 interaction, the crucial step for SARS-CoV-2 infection. Extensive computational analyses show that a chimeric ACE2-Fragment crystallizable (ACE2-Fc) construct mimics the native receptor dimeric conformation. ACE2-Fc functionalized gFET allows in vitro detection of the trimeric Spike protein, outperforming functionalization with a diagnostic antibody or with the soluble ACE2 portion, resulting in a sensitivity of 20 pg/mL. Our miniaturized POC biosensor successfully detects B.1.610 (pre-VOC), Alpha, Beta, Gamma, Delta, Omicron (i.e., BA.1, BA.2, BA.4, BA.5, BA.2.75 and BQ.1) variants in isolated viruses and patient's clinical nasopharyngeal swabs. The biosensor reached a Limit Of Detection (LOD) of 65 cps/mL in swab specimens of Omicron BA.5. Our approach paves the way for a new and reusable class of highly sensitive, rapid and variant-robust SARS-CoV-2 detection systems.

Original languageEnglish
Article number101729
JournalNano Today
Volume48
DOIs
Publication statusPublished - Feb 2023
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Biosensor
  • Centaurus
  • Cerberus
  • Molecular dynamics
  • Omicron
  • Point-of-care
  • SARS-CoV-2 variants
  • gFET

ASJC Scopus subject areas

  • Biotechnology
  • Bioengineering
  • Biomedical Engineering
  • General Materials Science
  • Pharmaceutical Science

Fingerprint

Dive into the research topics of 'SARS-CoV-2 multi-variant rapid detector based on graphene transistor functionalized with an engineered dimeric ACE2 receptor'. These topics are generated from the title and abstract of the publication. Together, they form a unique fingerprint.

Cite this